Antiretroviral treatment and age‐related comorbidities in a cohort of older HIV‐infected patientsGiovanna Orlando, A. Cargnel, Michela Fasolo et al.|HIV Medicine|2006Cited by 75
Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugsAmedeo Capetti, Giuliano Rizzardini, Mariangela Micale et al.|Medicine|2017Cited by 3
Durability of Boosted Atazanavir (ATV) or Darunavir (DRV) Plus Maraviroc (MVC) Dual rescue Therapy in Poorly Adherent Subjects in View of Long-Acting DrugsAmedeo Capetti, Giuliano Rizzardini, Gianfranco Dedivitiis et al.|Journal of Antivirals & Antiretrovirals|2017Cited by 1